Providence Therapeutics CEO Brad Sorenson says his company’s made-in-Canada coronavirus vaccine, the first to begin clinical trials, as he has said previously, needs more support from the federal government. To read more: »»» Subscribe to CBC News to watch more…
![How to evaluate emerging vitamin D and COVID-19 intervention trials | Roger Seheult How to evaluate emerging vitamin D and COVID-19 intervention trials | Roger Seheult](https://www.vitaminrush.com/wp-content/uploads/2021/04/1619780047_maxresdefault-1170x508.jpg)